Propantheline (Br)
Overview
Propantheline (Br) is antimuscarinic with action, uses and adverse effects similar to those of atropine. Propantheline (Br) is used as an antispasmodic for gastro-intestinal and urinary complaints. Propantheline (Br) is also reduces the secretion of gastric acid and used in peptic ulcer disease.
Categories
- 17 Gastrointestinal drugs
Primary Characterstics
Indications
Propantheline (Br) is primarily indicated in conditions like Adjunctive treatment of partial seizures, Diverticulitis, Duodenal ulcer, GI motality disorder, Hyperhidrosis, Menieres disease, Peptic ulcer, Symptomatic relief of GI-disorders, Urgency and incontinence, and can also be given in adjunctive therapy as an alternative drug of choice in Enuresis, Pancreatitis, Short bowel syndrome.
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Propantheline (Br)'s dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 15 mg | 15 (15) | 8 hourly | PO | 1 hour before meal. |
Paedriatic Dosage (20kg)
|
| 0.375 mg/kg | 0.38 (0.375) | 6 hourly | oral | |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Propantheline (Br) is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Tab
Store Below 40°C. Protect from Sunlight and Moisture.
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Propantheline (Br)
Back to top
Manufacturers of
Propantheline (Br)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic